NanJing Pharmaceutical Co Ltd (600713) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NanJing Pharmaceutical Co Ltd (600713) has a cash flow conversion efficiency ratio of -0.119x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-942.93 Million ≈ $-137.98 Million USD) by net assets (CN¥7.95 Billion ≈ $1.16 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
NanJing Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how NanJing Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 600713 current and long-term liabilities for a breakdown of total debt and financial obligations.
NanJing Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NanJing Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
UWM Holdings Corp
NYSE:UWMC
|
0.065x |
|
Anhui Gujing Distillery Co Ltd
SHE:200596
|
-0.055x |
|
SFL Corporation Ltd
F:UG6
|
0.067x |
|
Banco Patagonia
BA:BPAT
|
-0.006x |
|
Penguin Solutions, Inc.
NASDAQ:PENG
|
0.051x |
|
Bank Artos Indonesia Tbk PT
JK:ARTO
|
0.155x |
|
Hartalega Holdings Bhd
KLSE:5168
|
0.049x |
|
Xi'an Manareco New Materials Co.Ltd
SHG:688550
|
0.045x |
Annual Cash Flow Conversion Efficiency for NanJing Pharmaceutical Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of NanJing Pharmaceutical Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see market value of NanJing Pharmaceutical Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥7.79 Billion ≈ $1.14 Billion |
CN¥2.14 Billion ≈ $312.53 Million |
0.274x | +4.36% |
| 2023-12-31 | CN¥7.25 Billion ≈ $1.06 Billion |
CN¥1.91 Billion ≈ $278.97 Million |
0.263x | +357.83% |
| 2022-12-31 | CN¥6.69 Billion ≈ $979.67 Million |
CN¥-682.31 Million ≈ $-99.84 Million |
-0.102x | -176.71% |
| 2021-12-31 | CN¥5.23 Billion ≈ $765.86 Million |
CN¥695.33 Million ≈ $101.75 Million |
0.133x | +155.57% |
| 2020-12-31 | CN¥4.82 Billion ≈ $705.34 Million |
CN¥-1.15 Billion ≈ $-168.64 Million |
-0.239x | -207.64% |
| 2019-12-31 | CN¥4.52 Billion ≈ $661.42 Million |
CN¥1.00 Billion ≈ $146.91 Million |
0.222x | +348.76% |
| 2018-12-31 | CN¥4.11 Billion ≈ $601.30 Million |
CN¥-366.90 Million ≈ $-53.69 Million |
-0.089x | -188.92% |
| 2017-12-31 | CN¥3.19 Billion ≈ $466.29 Million |
CN¥319.99 Million ≈ $46.82 Million |
0.100x | +227.96% |
| 2016-12-31 | CN¥3.07 Billion ≈ $449.14 Million |
CN¥-240.88 Million ≈ $-35.25 Million |
-0.078x | +31.12% |
| 2015-12-31 | CN¥2.69 Billion ≈ $393.13 Million |
CN¥-306.08 Million ≈ $-44.79 Million |
-0.114x | +18.57% |
| 2014-12-31 | CN¥2.44 Billion ≈ $356.66 Million |
CN¥-341.01 Million ≈ $-49.90 Million |
-0.140x | +49.13% |
| 2013-12-31 | CN¥1.29 Billion ≈ $188.48 Million |
CN¥-354.27 Million ≈ $-51.84 Million |
-0.275x | -314.86% |
| 2012-12-31 | CN¥1.31 Billion ≈ $192.23 Million |
CN¥168.17 Million ≈ $24.61 Million |
0.128x | +125.10% |
| 2011-12-31 | CN¥1.36 Billion ≈ $198.74 Million |
CN¥-692.53 Million ≈ $-101.34 Million |
-0.510x | -641.23% |
| 2010-12-31 | CN¥1.26 Billion ≈ $184.95 Million |
CN¥119.08 Million ≈ $17.42 Million |
0.094x | +247.07% |
| 2009-12-31 | CN¥744.78 Million ≈ $108.98 Million |
CN¥20.22 Million ≈ $2.96 Million |
0.027x | +283.11% |
| 2008-12-31 | CN¥610.69 Million ≈ $89.36 Million |
CN¥4.33 Million ≈ $633.18K |
0.007x | -93.87% |
| 2007-12-31 | CN¥700.93 Million ≈ $102.57 Million |
CN¥81.08 Million ≈ $11.86 Million |
0.116x | -53.82% |
| 2006-12-31 | CN¥643.97 Million ≈ $94.23 Million |
CN¥161.31 Million ≈ $23.61 Million |
0.250x | -2.12% |
| 2005-12-31 | CN¥646.94 Million ≈ $94.67 Million |
CN¥165.57 Million ≈ $24.23 Million |
0.256x | +866.48% |
| 2004-12-31 | CN¥614.14 Million ≈ $89.87 Million |
CN¥16.26 Million ≈ $2.38 Million |
0.026x | -15.90% |
| 2003-12-31 | CN¥611.84 Million ≈ $89.53 Million |
CN¥19.27 Million ≈ $2.82 Million |
0.031x | -76.86% |
| 2002-12-31 | CN¥505.29 Million ≈ $73.94 Million |
CN¥68.75 Million ≈ $10.06 Million |
0.136x | +1628.15% |
| 2001-12-31 | CN¥472.04 Million ≈ $69.07 Million |
CN¥-4.20 Million ≈ $-615.03K |
-0.009x | -104.94% |
| 2000-12-31 | CN¥486.93 Million ≈ $71.25 Million |
CN¥87.68 Million ≈ $12.83 Million |
0.180x | +58.29% |
| 1999-12-31 | CN¥444.61 Million ≈ $65.06 Million |
CN¥50.58 Million ≈ $7.40 Million |
0.114x | -37.30% |
| 1998-12-31 | CN¥426.92 Million ≈ $62.47 Million |
CN¥77.45 Million ≈ $11.33 Million |
0.181x | -- |
About NanJing Pharmaceutical Co Ltd
Nanjing Pharmaceutical Group Company Limited engages in the drug distribution businesses in China. It also involved in the wholesale and retail of medical device distribution; pharmaceutical logistics; and internet drug retail business. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nan… Read more